DPR

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameDPR
Drug Alias NameCis-diamminedichloroplatinum (II)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A